Azacitidine (Sandoz Inc)
Welcome to the PulseAid listing for the Azacitidine drug offered from Sandoz Inc. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sandoz Inc |
NON-PROPRIETARY NAME: | azacitidine |
SUBSTANCE NAME: | AZACITIDINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | INTRAVENOUS; SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2013-09-16 |
END MARKETING DATE: | 0000-00-00 |
Azacitidine HUMAN PRESCRIPTION DRUG Details:
Item Description | Azacitidine from Sandoz Inc |
LABELER NAME: | Sandoz Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/1) |
START MARKETING DATE: | 2013-09-16 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0781-3253_c62745c5-18d0-4638-b7e0-0b3fd8eec0a0 |
PRODUCT NDC: | 0781-3253 |
APPLICATION NUMBER: | NDA050794 |
Other AZACITIDINE Pharmaceutical Manufacturers / Labelers: